| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
82,159 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,395,452 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,159 |
|
|
| Total
Value |
$6,395,452 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-05-30 |
72,159 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
139 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-03-15 |
4 |
D |
$83.57 |
$25,823 |
D/D |
(309) |
12,609 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$1,743,573 |
D/D |
(20,789) |
71,859 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-06-29 |
4 |
D |
$83.92 |
$48,338 |
D/D |
(576) |
38,063 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-03-16 |
4 |
D |
$84.10 |
$29,099 |
D/D |
(346) |
12,263 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$110,104 |
D/D |
(1,303) |
18,465 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$87.74 |
$237,600 |
D/D |
(2,708) |
59,558 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-02-03 |
4 |
D |
$87.77 |
$94,089 |
D/D |
(1,072) |
29,709 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-03-22 |
4 |
D |
$88.05 |
$36,541 |
D/D |
(415) |
16,613 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-06-29 |
4 |
D |
$88.93 |
$869,735 |
D/D |
(9,780) |
45,805 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-11-26 |
4 |
S |
$88.97 |
$302,508 |
D/D |
(3,400) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-05-10 |
4 |
AS |
$89.50 |
$219,275 |
D/D |
(2,450) |
15,396 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-07-08 |
4 |
AS |
$89.50 |
$656,662 |
D/D |
(7,337) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2016-06-03 |
4 |
D |
$90.00 |
$33,840 |
D/D |
(376) |
14,547 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-01 |
4 |
S |
$90.25 |
$627,238 |
D/D |
(6,950) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-06-02 |
4 |
D |
$90.72 |
$34,111 |
D/D |
(376) |
12,885 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-03-16 |
4 |
D |
$90.96 |
$34,201 |
D/D |
(376) |
13,290 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-05-08 |
4 |
AS |
$91.17 |
$687,334 |
D/D |
(7,482) |
13,468 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-05-15 |
4 |
D |
$91.50 |
$18,941 |
D/D |
(207) |
13,261 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-02 |
4 |
S |
$91.82 |
$459,100 |
D/D |
(5,000) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-04 |
4 |
D |
$92.07 |
$31,856 |
D/D |
(346) |
15,050 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-03-15 |
4 |
D |
$92.50 |
$31,080 |
D/D |
(336) |
13,666 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$371,118 |
D/D |
(3,973) |
55,585 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-04-05 |
4 |
AS |
$94.00 |
$277,582 |
D/D |
(2,953) |
13,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-15 |
4 |
AS |
$94.50 |
$190,985 |
D/D |
(2,021) |
13,029 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
AS |
$94.50 |
$330,750 |
D/D |
(3,500) |
30,726 |
0 |
- |
|
139 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
